Methyltransferase like 3 (METTL3) reverses the transcriptional activity of TFEB by binding to the 3’-UTR end of TFEB and concomitantly methylating two m6A residues, thus playing a protective role in ischemic heart disease (Song H. et al., 2019). This evidence concerns the gene METTL3 and coronary artery disorder.